CareDx (CDNA) has had the highest return since July 30, 2026 by a mid-cap US stock, returning 148.5%.
| ASSET | % RETURN |
|---|---|
CareDx (CDNA) | 148.47% |
Kodiak Sciences (KOD) | 142.38% |
Heartflow, Inc Common Stock (HTFL) | 135.45% |
Abcellera Biologics (ABCL) | 121.88% |
GRAIL, LLC (GRAL) | 120.49% |
Figs (FIGS) | 101.04% |
Strive (ASST) | 95.72% |
Amplitude (AMPL) | 95.2% |
Iovance Biotherapeutics (IOVA) | 87.2% |
Okeanis Eco Tankers (ECO) | 86.67% |
Tenable (TENB) | 82.16% |
Schrodinger (SDGR) | 80.69% |
Hyperliquid Strategies Inc Common Stock (PURR) | 80.49% |
Braze (BRZE) | 77.46% |
Appian (APPN) | 76.24% |
Qualys (QLYS) | 69.8% |
NIQ Global Intelligence (NIQ) | 65.04% |
Bausch Health Companies (BHC) | 64.99% |
Gitlab (GTLB) | 64.51% |
Accelerant (ARX) | 63.8% |
Abercrombie & Fitch (ANF) | 63.39% |
CVR Energy (CVI) | 62.66% |
VEON (VEON) | 61.94% |
Absci (ABSI) | 59% |
Standard Nuclear (STDN) | 57.92% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.